Deutsche Bank Ag\ Bio N Tech Se Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Bio N Tech Se stock. As of the latest transaction made, Deutsche Bank Ag\ holds 297,751 shares of BNTX stock, worth $33.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

297,751

Previous 350,554 15.06%

Holding current value

$33.2 Million

Previous $28.2 Million 25.53%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.36 - $124.66 $4.14 Million - $6.58 Million	-52,803 Reduced 15.06%	297,751 $35.4 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $11.8 Million - $15.1 Million	-146,914 Reduced 29.53%	350,554 $28.2 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $3.5 Million - $4.42 Million	-39,385 Reduced 7.34%	497,468 $45.9 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $874,736 - $1.08 Million	-9,622 Reduced 1.76%	536,853 $56.7 Million
Q3 2023 Nov 09, 2023	SELL	$98.5 - $125.08 $3.92 Million - $4.98 Million	-39,786 Reduced 6.79%	546,475 $59.4 Million
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $3.45 Million - $4.36 Million	-33,597 Reduced 5.42%	586,261 $63.3 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $1.38 Million - $1.73 Million	11,266 Added 1.85%	619,858 $77.2 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $4.7 Million - $7.39 Million	-39,727 Reduced 6.13%	608,592 $91.4 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $280,957 - $403,025	-2,201 Reduced 0.34%	648,319 $87.4 Million
Q2 2022 Aug 11, 2022	BUY	$123.25 - $186.24 $16.1 Million - $24.4 Million	130,824 Added 25.17%	650,520 $97 Million
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $12.9 Million - $23.7 Million	-102,237 Reduced 16.44%	519,696 $88.6 Million
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $75.4 Million - $126 Million	348,243 Added 127.24%	621,933 $160 Million
Q3 2021 Nov 04, 2021	SELL	$205.93 - $447.23 $26.9 Million - $58.3 Million	-130,425 Reduced 32.27%	273,690 $74.7 Million
Q2 2021 Aug 11, 2021	SELL	$113.32 - $241.49 $2.51 Million - $5.34 Million	-22,111 Reduced 5.19%	404,115 $90.5 Million
Q1 2021 May 13, 2021	BUY	$85.73 - $119.5 $25.7 Million - $35.8 Million	299,332 Added 235.89%	426,226 $46.5 Million
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $27.1 Million - $48.3 Million	-372,755 Reduced 74.6%	126,894 $10.3 Million
Q3 2020 Nov 12, 2020	SELL	$57.81 - $104.17 $1.47 Million - $2.65 Million	-25,426 Reduced 4.84%	499,649 $34.6 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $19.2 Million - $33.3 Million	498,260 Added 1858.14%	525,075 $35 Million
Q1 2020 May 14, 2020	SELL	$28.55 - $92.0 $233,681 - $753,020	-8,185 Reduced 23.39%	26,815 $1.57 Million
Q4 2019 Feb 14, 2020	BUY	$12.75 - $36.91 $446,250 - $1.29 Million	35,000 New	35,000 $1.19 Million

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account